Data and classifications added to biochemicals dataset

It has been a year since I last shared insight from our biochemicals dataset here on our blog, so today I’m going to look at this data again and see how it has developed and changed in that time, and outline any new considerations in this market. 

In the past year I have not only been growing the size of this dataset, but also working to broaden its scope. 

The amount of data we have around biochemicals usage has grown significantly – we have a 66 per cent increase in citations and 150,000 additional products in this dataset since this time last year. We also have 20 additional suppliers covered. 

Last year I mentioned that one of my next areas of focus was to add information on structural classification of biochemicals – that has now been started and we now include products of various classifications. 

Our initial focus when we started this dataset three years ago was on the bioactive small molecules, such as inhibitors and activators, and on lipids, but I’m now also collecting information on carbohydrates, amino acids, peptides, nucleotides and nucleosides and others.

“Pasta bow ties, X-ray” Credit: Chris Thorn
Carbohydrates – just one of the classifications we’ve added to our biochemicals dataset!

This means that when researchers use our biochemical search engine, they are now searching a larger number of products with a greater amount of detail, from a wider variety of suppliers. 

It also means that our biochemicals dataset can give suppliers enhanced insight into the global biochemical market. 

Using the classification data,  suppliers can now see which companies hold the most market share for specific classes of biochemicals, those that are on a growth trajectory, and those that might be struggling against the competition.

Suppliers can also examine the market for individual biochemicals and identify the most valuable products to add to their catalogues. 

While the changes to this dataset haven’t changed the top supplier list significantly, with the newly merged MilliporeSigma very much claiming the lion’s share of the market, among the remaining companies in the top ten there is very close competition and a lot of opportunity for market gain.

If there are other classifications you’d like to see me include in this dataset in addition to structural classifications, please do get in touch and let me know.

– Rebecca and the CiteAb team 

About the author

Join thousands of people who already enjoy the CiteAb newsletter

To keep up to date with the latest developments to our search engine, news from our life science market data analysis and improvements to our citation provision.